Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
Q1 2025 vs. Q4 2024
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 33 | 36 | +3 |
| Shares | 1.10M | 5.46M | +4.36M (+395.2%) |
| Value | $1.27M | $3.09M | +$1.82M (+144.1%) |
New holders (8)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 3,322,000 | $1.88M | 0.05% |
| Belpointe Asset Management LLC | 249,833 | $141.5K | 0.01% |
| Two Sigma Securities, LLC | 20,259 | $11.5K | 0.00% |
| XTX Topco Ltd | 16,034 | $9.08K | 0.00% |
| Commonwealth Equity Services, LLC | 13,500 | $8.00K | 0.00% |
| GWM Advisors LLC | 11,000 | $6.23K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,116 | $2.90K | 0.00% |
| SBI Securities Co., Ltd. | 300 | $170 | 0.00% |
Sold out (5)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Millennium Management LLC | 136,137 | $156.6K |
| Jane Street Group, LLC | 33,437 | $38.5K |
| Goldman Sachs Group Inc | 17,509 | $20.1K |
| HRT Financial LP | 15,751 | $18.0K |
| IFP Advisors, Inc | 3,500 | $4.03K |